Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report

BACKGROUND: Anaplastic lymphoma kinase (ALK) fusion is an important oncogenic driver in non-small cell lung cancer (NSCLC). Reports on the intergenic region (IGR) as an ALK fusion partner are rare. Here, we report the case of a patient with advanced NSCLC harboring a human immunodeficiency virus typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Xiaodong, Wang, Wenxian, Wu, Wei, Zhang, Yiping, Shao, Lan, Santarpia, Mariacarmela, Christopoulos, Petros, Myall, Nathaniel J., Shi, Zhiyong, Lou, Guangyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
iMDT Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186176/
https://www.ncbi.nlm.nih.gov/pubmed/35693284
http://dx.doi.org/10.21037/tlcr-22-288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186176/
https://www.ncbi.nlm.nih.gov/pubmed/35693284
http://dx.doi.org/10.21037/tlcr-22-288

Ejemplares similares